Indraprastha Medical Corporation Ltd - 532150 - Disclosures Of Related Party Transactions
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2019. This is for your information and record. Indraprastha Medical Corporation Ltd - 532150 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report13/05/2019 3 Name of the Certifying Firm BALDEV SINGH KASHTWAL 4 Name of the Certifying Individual BALDEV SINGH KASHTWAL 5Membership TypeFCS 6 Membership Number 3616 7 CP No. 3169 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes Indraprastha Medical Corporation Ltd - 532150 - Board recommends Dividend
Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2019, inter alia, has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share for the financial year 2018-19.Dividend if approved by shareholders will be paid on or before 30th October, 2019. Indraprastha Medical Corporation Ltd - 532150 - Results For The Quarter And Year Ended 31St March, 2019
1. The Audited Financial results of the company for the quarter and financial year ended 31st March 2019. Please find enclosed audited financial results for the quarter and financial year ended 31st March, 2019 along with a copy of the unmodified Audit Report by the Statutory Auditors of the Company. In terms of second proviso to regulation 33(3)(d) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, a declaration by CFO confirming that the Auditors have given an Unmodified Opinion on the Annual Audited Financial Results of the Company for the financial year ended 31st March 2019, is also enclosed. Indraprastha Medical Corporation Ltd - 532150 - Outcome of Board Meeting
Pursuant to provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) we wish to inform you that the Board of Directors at its meeting held today i.e. on 8th May, 2019, have approved: 1. The Audited Financial results of the company for the quarter and financial year ended 31st March 2019. Please find enclosed audited financial results for the quarter and financial year ended 31st March, 2019 along with a copy of the unmodified Audit Report by the Statutory Auditors of the Company. 2. Recommendation of Dividend Pursuant to Regulation 30 & 43 of the Listing Regulations, we wish to inform you that the Board of Directors of the Company, recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share for the financial year 2018-19. The Board meeting commenced at 3.00 p.m. and ended at 6.25 p.m. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Pursuant to the provisions of Regulation 39 of the the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that we have received requests from the shareholders for issue of duplicate share certificates in lieu of share certificates reported lost, as per details enclosed. Thanking You, Sincerely Yours, A.K.SINGHAL INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayINDRAPRASTHA MEDICAL CORP.LTD. 2CININE681B01017 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 21 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: AJAY KUMAR SINGHAL Designation: VICE PRESIDENT CUM COMPANY SECRETARY EmailId: [email protected] Name of the Chief Financial Officer: C P TYAGI Designation: CHIEF FINANCIAL OFFICER EmailId: [email protected] Date: 25/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31, 2019 And Dividend
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 8th May, 2019, inter alia :- (i) to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2019, and (ii) to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2018-19. This is for your information and record. Indraprastha Medical Corporation Ltd - 532150 - Shareholding for the Period Ended March 31, 2019
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here